Skip to main content
Smart Investors Daily
HC

NASDAQ · HCAT

Health Catalyst, Inc.

Healthcare · Medical - Healthcare Information Services

$1.29

Up+$0.00 (+0.00%)

Updated Nov 20, 2026, 2:28 AM

SID Score

2.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
181.07M
P/E ratio
-1.78
Dividend yield
0.00%
52-week range
$0.96 – $3.03
Volume
442.42K
Avg. volume
637.29K

Price performance · HCAT

HCAT price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

HCAT closed at $1.29 after 21 trading sessions, down 25.86% for the selected period.

Last close
$1.29
Period change
-25.86%
Period low
$1.29
Period high
$1.80
Daily close
View OHLC price history
HCAT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$1.29$1.40$1.29$1.29442.42K
Nov 18, 2026$1.35$1.39$1.27$1.29269.25K
Nov 17, 2026$1.38$1.395$1.31$1.37142.41K
Nov 16, 2026$1.49$1.49$1.38$1.38221.79K
Nov 13, 2026$1.37$1.55$1.36$1.51465.29K
Nov 12, 2026$1.46$1.48$1.34$1.36686.7K
Nov 11, 2026$1.49$1.50$1.39$1.43610K
Nov 10, 2026$1.51$1.525$1.3506$1.44403.87K
Nov 9, 2026$1.57$1.60$1.43$1.51532.95K
Nov 6, 2026$1.46$1.48$1.4027$1.46285.77K
Nov 5, 2026$1.59$1.59$1.45$1.50336.35K
Nov 4, 2026$1.50$1.605$1.49$1.59310.81K
Nov 3, 2026$1.51$1.57$1.435$1.44525.98K
Nov 2, 2026$1.72$1.77$1.58$1.58247.12K
Oct 30, 2026$1.79$1.84$1.66$1.69344.99K
Oct 29, 2026$1.80$1.835$1.77$1.79282.31K
Oct 28, 2026$1.60$1.835$1.57$1.80695.48K
Oct 27, 2026$1.63$1.64$1.565$1.57355.75K
Oct 26, 2026$1.66$1.675$1.62$1.63197.86K
Oct 23, 2026$1.73$1.735$1.69$1.69167.4K
Oct 22, 2026$1.75$1.775$1.71$1.74165.62K

Latest HCAT news

The latest Smart Investors Daily articles mentioning HCAT.

HCAT research

Overview

Company profile and research snapshot.

Company profile

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$4.25
Implied upside
—
Analysts
—
HCAT recent ratings
DateFirmRatingTarget
Aug 21, 2026Canaccord GenuityHold—
Aug 13, 2026Wells FargoEqual-Weight—
Aug 11, 2026CitigroupNeutral—
Jul 21, 2026Canaccord GenuityBuy—
Jun 26, 2026Wells FargoEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 9, 2026

HCAT Q3 2026 deep dive: client retention and cost alignment take center stage

Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) beat Wall Street’s revenue expectations in Q3 2026, but sales fell by 26.3% year on year to $56.28 million. The company expects the full year’s revenue to be around $247.5 million, close to analysts’ estimates. Its non-GAAP loss of $0.03 per share was $0.02 above analysts’ consensus estimates.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.